HUP0202638A2 - Use of fermented wheat-germ extract for preparation of antiphlogistic compositions - Google Patents

Use of fermented wheat-germ extract for preparation of antiphlogistic compositions

Info

Publication number
HUP0202638A2
HUP0202638A2 HU0202638A HUP0202638A HUP0202638A2 HU P0202638 A2 HUP0202638 A2 HU P0202638A2 HU 0202638 A HU0202638 A HU 0202638A HU P0202638 A HUP0202638 A HU P0202638A HU P0202638 A2 HUP0202638 A2 HU P0202638A2
Authority
HU
Hungary
Prior art keywords
preparation
germ extract
fermented wheat
antiphlogistic
compositions
Prior art date
Application number
HU0202638A
Other languages
Hungarian (hu)
Inventor
Máté Hidvégi
Ákos Resetár
Original Assignee
Máté Hidvégi
Ákos Resetár
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Máté Hidvégi, Ákos Resetár filed Critical Máté Hidvégi
Priority to HU0202638A priority Critical patent/HUP0202638A3/en
Publication of HU0202638D0 publication Critical patent/HU0202638D0/hu
Priority to PL03375391A priority patent/PL375391A1/en
Priority to MXPA05001469A priority patent/MXPA05001469A/en
Priority to EP03784303A priority patent/EP1536809A1/en
Priority to JP2004527076A priority patent/JP2006501214A/en
Priority to AU2003255854A priority patent/AU2003255854A1/en
Priority to PCT/HU2003/000065 priority patent/WO2004014406A1/en
Priority to CNA038189003A priority patent/CN1674924A/en
Priority to EA200500326A priority patent/EA007844B1/en
Priority to CA002494744A priority patent/CA2494744A1/en
Priority to BR0313589-6A priority patent/BR0313589A/en
Priority to KR1020057002283A priority patent/KR20050059066A/en
Publication of HUP0202638A2 publication Critical patent/HUP0202638A2/en
Priority to HR20050114A priority patent/HRP20050114A2/en
Priority to IL16673205A priority patent/IL166732A0/en
Priority to NO20051168A priority patent/NO20051168L/en
Publication of HUP0202638A3 publication Critical patent/HUP0202638A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány fermentált búzacsíra-kivonat, kereskedelmi néven Avemar<új terápiás alkalmazására vonatkozik, közelebbrőlgyulladáscsökkentőként, elsősorban ízületi gyulladásos állapotok(arthritis) kezelésére és/vagy megelőzésére és/vagy csökkentésérealkalmas gyógyszerkészítmények előállítására. ÓThe invention relates to the new therapeutic use of fermented wheat germ extract, under the trade name Avemar, more specifically as an anti-inflammatory agent, primarily for the treatment and/or prevention and/or reduction of arthritis. HE

HU0202638A 2002-08-09 2002-08-09 Use of fermented wheat-germ extract for preparation of antiphlogistic compositions HUP0202638A3 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
HU0202638A HUP0202638A3 (en) 2002-08-09 2002-08-09 Use of fermented wheat-germ extract for preparation of antiphlogistic compositions
KR1020057002283A KR20050059066A (en) 2002-08-09 2003-08-08 Use of fermented wheat germ extract as anti-inflammatory agent
PCT/HU2003/000065 WO2004014406A1 (en) 2002-08-09 2003-08-08 Use of fermented wheat germ extract as anti-inflammatory agent
EA200500326A EA007844B1 (en) 2002-08-09 2003-08-08 Use of fermented wheat germ extract as anti-inflammatory agent
EP03784303A EP1536809A1 (en) 2002-08-09 2003-08-08 Use of fermented wheat germ extract as anti-inflammatory agent
JP2004527076A JP2006501214A (en) 2002-08-09 2003-08-08 Use of fermented wheat germ extract as anti-inflammatory agent
AU2003255854A AU2003255854A1 (en) 2002-08-09 2003-08-08 Use of fermented wheat germ extract as anti-inflammatory agent
PL03375391A PL375391A1 (en) 2002-08-09 2003-08-08 Use of fermented wheat germ extract as anti-inflammatory agent
CNA038189003A CN1674924A (en) 2002-08-09 2003-08-08 Use of fermented malt extract as anti-inflammatory agent
MXPA05001469A MXPA05001469A (en) 2002-08-09 2003-08-08 Use of fermented wheat germ extract as anti-inflammatory agent.
CA002494744A CA2494744A1 (en) 2002-08-09 2003-08-08 Use of fermented wheat germ extract as anti-inflammatory agent
BR0313589-6A BR0313589A (en) 2002-08-09 2003-08-08 Use of fermented wheat germ extract as anti-inflammatory agent
HR20050114A HRP20050114A2 (en) 2002-08-09 2005-02-03 Use of fermented wheat germ extract as anti-inflammatory agent
IL16673205A IL166732A0 (en) 2002-08-09 2005-02-07 Use of fermented wheat germ extract as anti-inflammatory agent
NO20051168A NO20051168L (en) 2002-08-09 2005-03-04 Use of fermented wheat germ extract as anti-inflammatory agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0202638A HUP0202638A3 (en) 2002-08-09 2002-08-09 Use of fermented wheat-germ extract for preparation of antiphlogistic compositions

Publications (3)

Publication Number Publication Date
HU0202638D0 HU0202638D0 (en) 2002-10-28
HUP0202638A2 true HUP0202638A2 (en) 2004-06-28
HUP0202638A3 HUP0202638A3 (en) 2007-08-28

Family

ID=89980690

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202638A HUP0202638A3 (en) 2002-08-09 2002-08-09 Use of fermented wheat-germ extract for preparation of antiphlogistic compositions

Country Status (15)

Country Link
EP (1) EP1536809A1 (en)
JP (1) JP2006501214A (en)
KR (1) KR20050059066A (en)
CN (1) CN1674924A (en)
AU (1) AU2003255854A1 (en)
BR (1) BR0313589A (en)
CA (1) CA2494744A1 (en)
EA (1) EA007844B1 (en)
HR (1) HRP20050114A2 (en)
HU (1) HUP0202638A3 (en)
IL (1) IL166732A0 (en)
MX (1) MXPA05001469A (en)
NO (1) NO20051168L (en)
PL (1) PL375391A1 (en)
WO (1) WO2004014406A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2908998A1 (en) * 2006-11-24 2008-05-30 Bao Quoc Ho Use of enzyme concentrate from cereal germ for therapeutic purposes to manufacture an anti inflammatory drug to treat arthritis and osteoarthritis
HUP0900614A2 (en) 2009-09-29 2011-05-30 Mate Dr Hidvegi Preparation comprising dehydrated, fermented material with amorphous crystaline structure and process for its production
WO2010135580A2 (en) * 2009-05-20 2010-11-25 The Regents Of The University Of California Fermented wheat germ proteins (fwgp) for the treatment of cancer
US20120164132A1 (en) * 2010-08-02 2012-06-28 Mate Hidvegi Anticancer and immunomodulating molecules and fractions containing said molecules, and process for preparing said fractions and said molecules from fermented vegetal material, and their uses
GB201108560D0 (en) 2011-05-20 2011-07-06 3 Ch Ltd Use of fermented wheat germ in the treatment of inflammatory bowel disease
GB201110746D0 (en) 2011-06-23 2011-08-10 Biropharma Uk Ltd Wheat germ derived material
JP6115995B2 (en) * 2013-04-24 2017-04-19 株式会社日清製粉グループ本社 Non-enzymatic saccharification reaction inhibitor
CN104381450A (en) * 2014-10-15 2015-03-04 张士远 Health milk for treatment of gastric mucosal injury and preparation method thereof
WO2017196048A1 (en) * 2016-05-11 2017-11-16 씨제이제일제당 (주) Externally applied composition for alleviating skin wrinkles, containing extract of fermented wheat germ product as active ingredient
WO2018056600A1 (en) * 2016-09-23 2018-03-29 씨제이제일제당 (주) Topical composition, for soothing skin, containing fermented wheat germ extract as active ingredient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07242537A (en) * 1994-03-04 1995-09-19 Kibun Foods Inc Production of substance having anti-inflammatory activity and anti-inflammatory agent
JPH08337536A (en) * 1995-06-14 1996-12-24 Asahi Breweries Ltd Agent for antiactive oxygen, antiactive oxygen agent, cosmetic, food and medicine containing the same as active ingredient
HU223344B1 (en) * 1997-08-13 2004-06-28 Máté Hidvégi Immunostimulant and metastasis-inhibiting fermented dried material, pharmaceutical compositions containing same, process for its production and its uses

Also Published As

Publication number Publication date
JP2006501214A (en) 2006-01-12
HUP0202638A3 (en) 2007-08-28
WO2004014406A1 (en) 2004-02-19
KR20050059066A (en) 2005-06-17
BR0313589A (en) 2005-07-12
CA2494744A1 (en) 2004-02-19
IL166732A0 (en) 2006-01-15
EA007844B1 (en) 2007-02-27
HU0202638D0 (en) 2002-10-28
HRP20050114A2 (en) 2005-10-31
EA200500326A1 (en) 2005-06-30
CN1674924A (en) 2005-09-28
NO20051168L (en) 2005-03-04
EP1536809A1 (en) 2005-06-08
PL375391A1 (en) 2005-11-28
AU2003255854A1 (en) 2004-02-25
MXPA05001469A (en) 2005-06-06

Similar Documents

Publication Publication Date Title
WO2004006858A3 (en) Compounds, compositions, and methods employing same
WO2003072035A8 (en) Compositions and methods for the treatment of immune related diseases
WO2004041170A9 (en) Compositions and methods for the treatment of immune related diseases
MXPA03011515A (en) Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents.
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
NO20042596L (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
WO2004024097A9 (en) Compositions and methods for the treatment of immune related diseases
MXPA04004837A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
AU2003218215A1 (en) Azolylaminoazines as inhibitors of protein kinases
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
AU2002311903A1 (en) Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto
WO2002069945A3 (en) Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
WO2004047792A3 (en) Liposomal glucocorticoids
TW200621765A (en) Substituted phenylaminothiazoles and their use
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
AU2003270498A1 (en) Topical veterinary compositions and methods for the treatment and prevention of infection
HUP0202638A2 (en) Use of fermented wheat-germ extract for preparation of antiphlogistic compositions
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
AU2003271807A1 (en) Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same
WO2004024076A8 (en) Novel compositions and methods for the treatment of immune related diseases
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
NO20054346L (en) Compositions and methods for the prevention and treatment of endotoxin-related diseases and conditions

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished